Literature DB >> 7414342

Classification, staging and end results of treatment of childhood non-Hodgkin's lymphomas: dissimilarities from lymphomas in adults.

S B Murphy.   

Abstract

Entities:  

Mesh：

Year:  1980        PMID： 7414342

Source DB:  PubMed          Journal:  Semin Oncol        ISSN： 0093-7754            Impact factor:   4.929


× No keyword cloud information.
  96 in total

Review 1.  Pediatric non-Hodgkin's lymphoma: clinical and biologic prognostic factors and risk allocation.

Authors:  Sheila Weitzman; Kaveri Suryanarayan; Howard J Weinstein
Journal:  Curr Oncol Rep       Date:  2002-03       Impact factor: 5.075

2.  Alpha 4 beta 7 integrin expression is associated with the leukemic evolution of human and murine T-cell lymphoblastic lymphomas.

Authors:  R Dolcetti; R Giardini; C Doglioni; R Cariati; F Pomponi; C D'Orazi; S Rao; A I Lazarovits; E C Butcher; M Boiocchi
Journal:  Am J Pathol       Date:  1997-05       Impact factor: 4.307

Review 3.  Burkitt lymphoma: staging and response evaluation.

Authors:  John T Sandlund
Journal:  Br J Haematol       Date:  2012-02-01       Impact factor: 6.998

4.  Intussusception in children: lessons learned from intestinal lymphoma as a rare lead-point.

Authors:  H R Bussell; S Kroiss; S J Tharakan; M Meuli; U Moehrlen
Journal:  Pediatr Surg Int       Date:  2019-05-28       Impact factor: 1.827

5.  Minimal disease assessment in the treatment of children and adolescents with intermediate-risk (Stage III/IV) B-cell non-Hodgkin lymphoma: a children's oncology group report.

Authors:  Bruce Shiramizu; Stanton Goldman; Ian Kusao; Melissa Agsalda; James Lynch; Lynette Smith; Lauren Harrison; Erin Morris; Thomas G Gross; Warren Sanger; Sherrie Perkins; Mitchell S Cairo
Journal:  Br J Haematol       Date:  2011-04-18       Impact factor: 6.998

Review 6.  Staging of common paediatric tumours.

Authors:  Hervé J Brisse
Journal:  Pediatr Radiol       Date:  2009-06

7.  Inferior outcomes of stage III T lymphoblastic lymphoma relative to stage IV lymphoma and T-acute lymphoblastic leukemia: long-term comparison of outcomes in the JACLS NHL T-98 and ALL T-97 protocols.

Authors:  Ryoji Kobayashi; Tetsuya Takimoto; Atsuko Nakazawa; Naoto Fujita; Ayumi Akazai; Kazumi Yamato; Makoto Yazaki; Takao Deguchi; Yoshiko Hashii; Koji Kato; Naoki Hatakeyama; Keizo Horibe; Hiroki Hori; Megumi Oda
Journal:  Int J Hematol       Date:  2014-05-07       Impact factor: 2.490

8.  Frequent mutations in SH2D1A (XLP) in males presenting with high-grade mature B-cell neoplasms.

Authors:  J T Sandlund; S A Shurtleff; M Onciu; E Horwitz; W Leung; V Howard; R Rencher; M E Conley
Journal:  Pediatr Blood Cancer       Date:  2013-04-15       Impact factor: 3.167

9.  Clinical and genetic characteristics of Japanese Burkitt lymphomas with or without leukemic presentation.

Authors:  Takeshi Namiki; Akiko Sakashita; Hirofumi Kobayashi; Nobuo Maseki; Toshiyuki Izumo; Yoshihiro Komada; Shoichi Koizumi; Takaaki Shikano; Atsushi Kikuta; Arata Watanabe; Junji Suzumiya; Masahiro Kikuchi; Yasuhiko Kaneko
Journal:  Int J Hematol       Date:  2003-06       Impact factor: 2.490

10.  Treatment of Burkitt lymphoma in equatorial Africa using a simple three-drug combination followed by a salvage regimen for patients with persistent or recurrent disease.

Authors:  Twalib Ngoma; Melissa Adde; Muheez Durosinmi; Jessie Githang'a; Yetunde Aken'Ova; Jane Kaijage; Oluwagbemiga Adeodou; Jamilla Rajab; Biobele J Brown; Lorenzo Leoncini; Kikkeri Naresh; Martine Raphael; Nina Hurwitz; Patricia Scanlan; Ama Rohatiner; David Venzon; Ian Magrath
Journal:  Br J Haematol       Date:  2012-07-30       Impact factor: 6.998
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.